×
Back to Agenda
Japan Town Hall
Session Chair(s)
Daisuke Koga, MSC
Director, Office of International Strategy and Planning
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
This session explores the benefits of drug development and approval in Japan, highlighting market size, development predictability, and regulatory support, with insights from administrative bodies and the international pharmaceutical industry.
Learning Objective : Recognize misconceptions about Japan's drug development environment and learn the latest updates; Discuss the benefits of drug development in Japan from regulatory and industry perspectives.
Have an account?